Difference between revisions of "OctPGMS pathway control state"
From Bioblast
ย |
|||
Line 8: | Line 8: | ||
This substrate combination supports convergent electron flow to the [[Q-junction]]. | This substrate combination supports convergent electron flow to the [[Q-junction]]. | ||
|info=[[MiPNet21.06 SUIT | |info=[[MiPNet21.06 SUIT RP]], [[SUIT reference protocol]] | ||
}} | }} | ||
::: ''More details'' ย | ::: ''More details'' ย | ||
Line 44: | Line 41: | ||
[[File:SUIT-Reference-Protocol 2.jpg|700px |SUIT RP2]]<br /> | [[File:SUIT-Reference-Protocol 2.jpg|700px |SUIT RP2]]<br /> | ||
---- | ---- | ||
{{MitoPedia concepts | |||
|mitopedia concept=SUIT state | |||
}} |
Latest revision as of 05:01, 19 July 2022
- high-resolution terminology - matching measurements at high-resolution
OctPGMS pathway control state
Description
OctPGMS: Octanoylcarnitine & Pyruvate & Glutamate & Malate & Succinate.
MitoPathway control state: FNS
SUIT protocol: SUIT-001, SUIT-002, SUIT-015
This substrate combination supports convergent electron flow to the Q-junction.
Abbreviation: OctPGMS
Reference: MiPNet21.06 SUIT RP, SUIT reference protocol
OctPMSL
FNS pathway in the LEAK state can be evaluated in the following SUIT protocols:
OctPMSP
FNS pathway in the OXPHOS state can be evaluated in the following SUIT protocols:
-
- DL-Protocol for isolated mitochondria and tissue homogenate (mt): SUIT-002 O2 mt D005
- DL-Protocol for permeabilized fibers (pfi): SUIT-002 O2 pfi D006
- DL-Protocol for permeabilized cells (pce): SUIT-002 O2 ce-pce D007
-
OctPMSE
FNS pathway in the ET state can be evaluated in the following SUIT protocols:
-
- DL-Protocol for isolated mitochondria and tissue homogenate (mt): SUIT-001 O2 mt D001
- DL-Protocol for permeabilized fibers (pfi): SUIT-001 O2 pfi D002
- DL-Protocol for permeabilized cells (pce): SUIT-001 O2 ce-pce D003
-
MitoPedia concepts:
SUIT state